Target intelligence / Profile preview

Hes family bHLH transcription factor 2 (HES2)

Target
HES2
Molecular classification
Transcription factor, Basic helix-loop-helix (bHLH) family, Hairy and enhancer of split family
01

Overview

Hes family bHLH transcription factor 2 (HES2) is a transcriptional repressor belonging to the basic helix-loop-helix (bHLH) and Hairy and enhancer of split (HES) family, encoded by the human HES2 gene[3][4][5]. HES2 contains conserved functional domains: a bHLH domain for DNA binding and dimerization, an Orange domain for partner specificity, and a WRPW motif for transcriptional repression[1]. It acts by repressing the transcription of genes regulated by other bHLH proteins, thereby influencing cell fate decisions, particularly promoting glial cell fate over neuronal fate during neurogenesis[2][3]. HES2 plays a role in regulating the balance between proliferation and differentiation of neural precursors, mainly through inhibition of proneural bHLH activators and interaction with other transcription factors. It is located in the cell nucleus and binds DNA in a sequence-specific manner[3][4]. Diseases associated with HES2 include campomelic dysplasia, and dysregulation of HES family members generally has implications in cancer and neurodevelopmental disorders[3]. There are currently no known drugs that specifically target HES2, nor are there described biomarker or safety concerns unique to this molecule in the literature.

Other names
Transcription factor HES-2HES2BHLHB40bHLHb40Class B basic helix-loop-helix protein 40Hairy and enhancer of split 2transcription factor HES-2class B basic helix-loop-helix protein 40
02

Biological functions

Regulation of neurogenesisTranscriptional repressionCell fate determinationGliogenesisInhibition of neuronal differentiationSequence-specific double-stranded DNA bindingDimerizationRegulation of cell proliferation
03

Disease associations

CancerCampomelic dysplasiaPotential roles in neurodevelopmental disorders

Beyond the preview

Go deeper on Hes family bHLH transcription factor 2 (HES2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hes family bHLH transcription factor 2 (HES2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call